113 related articles for article (PubMed ID: 15599849)
1. Head and neck cancer: the pursuit of molecular diagnostic markers.
Hasina R; Lingen MW
Semin Oncol; 2004 Dec; 31(6):718-25. PubMed ID: 15599849
[TBL] [Abstract][Full Text] [Related]
2. Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin.
Califano J; Westra WH; Koch W; Meininger G; Reed A; Yip L; Boyle JO; Lonardo F; Sidransky D
J Natl Cancer Inst; 1999 Apr; 91(7):599-604. PubMed ID: 10203278
[TBL] [Abstract][Full Text] [Related]
3. [Recent advances in early diagnosis of head and neck cancer in precision medicine era].
Min MK; Zhu MH; Zheng HL
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Nov; 31(22):1770-1774. PubMed ID: 29798197
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.
Colnot DR; Nieuwenhuis EJ; Kuik DJ; Leemans CR; Dijkstra J; Snow GB; van Dongen GA; Brakenhoff RH
Clin Cancer Res; 2004 Dec; 10(23):7827-33. PubMed ID: 15585614
[TBL] [Abstract][Full Text] [Related]
5. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications.
Tabor MP; Brakenhoff RH; van Houten VM; Kummer JA; Snel MH; Snijders PJ; Snow GB; Leemans CR; Braakhuis BJ
Clin Cancer Res; 2001 Jun; 7(6):1523-32. PubMed ID: 11410486
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic alterations and their molecular genetic correlates in head and neck squamous cell carcinoma: a next generation window to the biology of disease.
Gollin SM
Genes Chromosomes Cancer; 2014 Dec; 53(12):972-90. PubMed ID: 25183546
[TBL] [Abstract][Full Text] [Related]
7. Intraoperative molecular assessment for lymph node metastasis in head and neck squamous cell carcinoma using one-step nucleic acid amplification (OSNA) assay.
Matsuzuka T; Takahashi K; Kawakita D; Kohno N; Nagafuji H; Yamauchi K; Suzuki M; Miura T; Furuya N; Yatabe Y; Matsuo K; Omori K; Hasegawa Y
Ann Surg Oncol; 2012 Nov; 19(12):3865-70. PubMed ID: 22618721
[TBL] [Abstract][Full Text] [Related]
8. The Association and Clinical Significance of CDKN2A Promoter Methylation in Head and Neck Squamous Cell Carcinoma: a Meta-Analysis.
Zhou C; Shen Z; Ye D; Li Q; Deng H; Liu H; Li J
Cell Physiol Biochem; 2018; 50(3):868-882. PubMed ID: 30355925
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of head and neck squamous cell cancer biomarkers.
Polanska H; Raudenska M; Gumulec J; Sztalmachova M; Adam V; Kizek R; Masarik M
Oral Oncol; 2014 Mar; 50(3):168-77. PubMed ID: 24382422
[TBL] [Abstract][Full Text] [Related]
10. Models for Predicting Stage in Head and Neck Squamous Cell Carcinoma Using Proteomic and Transcriptomic Data.
Kaddi CD; Wang MD
IEEE J Biomed Health Inform; 2017 Jan; 21(1):246-253. PubMed ID: 26462248
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic value of E-cadherin, MMP-9, activated MMP-13 and anti-p53 antibodies in squamous cell carcinomas of head and neck].
Al Kassam D; Alvarez Marcos C; Blanco I; de Los Toyos JR; Llorente JL
Med Clin (Barc); 2007 Dec; 129(20):761-5. PubMed ID: 18093475
[TBL] [Abstract][Full Text] [Related]
12. Salivary epigenetic biomarkers in head and neck squamous cell carcinomas.
Lim Y; Sun CX; Tran P; Punyadeera C
Biomark Med; 2016; 10(3):301-13. PubMed ID: 26888346
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive study of smoking-specific microRNA alterations in head and neck squamous cell carcinoma.
Krishnan AR; Zheng H; Kwok JG; Qu Y; Zou AE; Korrapati A; Li PX; Califano JA; Hovell MF; Wang-Rodriguez J; Ongkeko WM
Oral Oncol; 2017 Sep; 72():56-64. PubMed ID: 28797462
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma.
de Carvalho AC; Scapulatempo-Neto C; Maia DC; Evangelista AF; Morini MA; Carvalho AL; Vettore AL
BMC Med; 2015 May; 13():108. PubMed ID: 25956054
[TBL] [Abstract][Full Text] [Related]
15. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathogenesis of head and neck squamous cell carcinoma.
Hardisson D
Eur Arch Otorhinolaryngol; 2003 Oct; 260(9):502-8. PubMed ID: 12736744
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
Hasina R; Hulett K; Bicciato S; Di Bello C; Petruzzelli GJ; Lingen MW
Cancer Res; 2003 Feb; 63(3):555-9. PubMed ID: 12566295
[TBL] [Abstract][Full Text] [Related]
18. Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma.
Li CY; Klohr S; Sadick H; Weiss C; Hoermann K; Schoenberg SO; Sadick M
J Nucl Med Technol; 2014 Sep; 42(3):181-7. PubMed ID: 24970897
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients.
de Carvalho AC; Kowalski LP; Campos AH; Soares FA; Carvalho AL; Vettore AL
Oral Oncol; 2012 Mar; 48(3):240-8. PubMed ID: 22104250
[TBL] [Abstract][Full Text] [Related]
20. The flow cytometric analysis of premalignant and malignant lesions in head and neck squamous cell carcinoma.
Abou-Elhamd KE; Habib TN
Oral Oncol; 2007 Apr; 43(4):366-72. PubMed ID: 16931118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]